Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
about
Pyridine Dinucleotides from Molecules to Man.Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery.P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo.Acute Axonal Degeneration Drives Development of Cognitive, Motor, and Visual Deficits after Blast-Mediated Traumatic Brain Injury in Mice.Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervationCacna1c: Protecting young hippocampal neurons in the adult brain.KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity.The Influence of Nicotinamide on Health and Disease in the Central Nervous System.Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate ReceptorsNeuroprotective efficacy of P7C3 compounds in primate hippocampusP7C3 Inhibits LPS-Induced Microglial Activation to Protect Dopaminergic Neurons Against Inflammatory Factor-Induced Cell Death and
P2860
Q38668667-53326449-2C50-4BB8-83F4-F1FA02F9C56AQ38668995-A855FC69-94D4-41B4-9255-D2D2265A6A0DQ38701632-77BA91DE-9C7F-4A9E-BC58-2EC0626B2146Q38797627-338D1383-111D-4710-A1FB-BCC77FEDB606Q39018573-E250A4AD-FDBF-4CD8-8139-D1E8FD4E73F5Q42367834-CDAC2320-BB28-4BD2-B1A1-C0F578AE739CQ47237987-8C73900E-D5C5-4B96-AEF9-DFCC89E7B216Q54968514-DCC8F2E5-2D4F-405F-B224-5E9D3E30F13EQ58694067-9FA86B61-6DD6-4472-A37D-EEA2E52132EDQ58695785-2A4CC91B-40AC-45D7-B960-24B7F3FAD839Q59136946-6668C012-55CE-4C11-9844-1E40A3271EDE
P2860
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
@nl
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@ast
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@en
type
label
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
@nl
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@ast
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@en
prefLabel
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
@nl
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@ast
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.
@en
P2093
P2860
P3181
P356
P1476
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
@en
P2093
Adam D Miller
Andrew A Pieper
Anthony J DeMarco
Edwin Vázquez-Rosa
Emily Stuebing
Héctor De Jesús-Cortés
Jacinth Naidoo
Jeremiah K Britt
Joseph M Ready
Lorraine Morlock
P2860
P2888
P3181
P356
10.1038/NPJPARKD.2015.10
P407
P577
2015-05-21T00:00:00Z
P6179
1002212176